Algo version: 0.98b
AMLX is listed at the NASDAQ Exchange
AMLX [AMLX]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is AMLX stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Amylyx Pharmaceuticals pays dividends. Last time was Monday 2nd of April 2018 where the investors holding the stock on Wednesday 28th of March 2018 were paid $0.42000 per share. Over the last 3 times between 2017 and 2018, Amylyx Pharmaceuticals has paid $1.02 with an average of $0.34 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Amylyx Pharmaceuticals 10 years ago, but if you had invested on Friday 7th of January 2022 when the price was $18.07, you would have made a loss of $-12.84 per share or -71.06%

Yes, the average daily trading liquidity for Amylyx Pharmaceuticals is $4.70 million. You should therefore be able to get in and out of your positions relatively fast.

Amylyx Pharmaceuticals has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Amylyx Pharmaceuticals to be medium [0.7 out of 1]